Labiotech.eu

News and Trends 15 Nov 2017

New British Biotech Receives £3M to Develop Small Molecules that Fight Cancer

NeoPhore, has received investment from Sixth Element Capital to develop small molecules that stimulate the immune system against cancer. Sixth Element Capital has invested £3M (€3.3M) in NeoPhore, a new spin-out from PhoreMost – a drug discovery company based in Cambridge, UK. NeoPhore has been set up to explore small molecules that could be used to stimulate […]

November 15, 2017 - 1 minutemin - By Alex Dale

moderna biontech personalized cancer vaccine

News and Trends 15 Nov 2017

US Biotech Unicorn Steps up Competition for BioNTech’s mRNA Personalized Cancer Vaccine

Moderna Therapeutics has started dosing patients with an mRNA-based personalized cancer vaccine that resembles another one being developed by BioNTech. Moderna Therapeutics has announced the start of a Phase 1 study with mRNA-4157, a therapy consisting of a cancer vaccine that is tailored to each patient’s individual tumor. In order to make this personalized treatment, […]

November 15, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 15 Nov 2017

Swiss Biotech Rakes in Biggest Fundraising of 2017 to Regenerate Heart Valves

Xeltis has raised a €45M Series C to boost the development of its pioneering medical device, RestoreX, which helps to replace damaged heart valves. Xeltis, based in Zurich, Switzerland, is a clinical-stage medical device company developing heart valves and blood vessels to allow the body to naturally restore heart valve function. The biotech has achieved a €45M […]

November 15, 2017 - 2 minutesmins - By Alex Dale

imcyse type 1 diabetes immunotherapy cure

News and Trends 15 Nov 2017

Update: Belgian Biotech Starts Human Trials for a Potential Type 1 Diabetes Cure

Update (15/11/2017): Imcyse has officially started recruiting patients to test its therapy for type 1 diabetes. The clinical trial will recruit up to 40 patients across 15 European centers, and the first patient has already enrolled at the Steno Diabetes Center in Copenhagen. Originally published on 30/05/2017 Imcyse will run its first clinical trial testing […]

November 15, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 15 Nov 2017

Spanish Scientists’ Discovery Could be the End of Antibiotic-Resistant Superbugs

Superbugs might not be so super for long, as Spanish scientists have found a way to block the mechanisms by which they develop antibiotic resistance. Researchers from the Spanish National Research Council (CSIC) have made a big breakthrough in the battle against antibiotic-resistant bacteria. In a study published in Cell, they designed molecules that block the cellular […]

November 15, 2017 - 3 minutesmins - By Alex Dale

topas therapeutics timm jessen interview

Interview 15 Nov 2017

Therapeutic Nanoparticle Companies Are Rare: Meet the CEO of One of Them

In our last BIO Europe interview, I caught up with CEO Timm Jessen of Topas Therapeutics to hear about the company’s nanoparticles. Founded in 2013 as a spinout from Evotec, Topas Therapeutics is developing nanoparticles for a whole range of diseases and with CEO Timm Jessen at the helm. He told me the story of […]

November 15, 2017 - 4 minutesmins - By Evelyn Warner

News and Trends 14 Nov 2017

This British Biotech Could Treat T-Cell Lymphoma without Leaving the Body Unprotected

Autolus has revealed a new strategy to treat T-cell lymphoma without harming healthy, protective T cells. The therapy is expected to start human tests soon. T-cell lymphoma is a form of cancer that affects the cells responsible for protecting our body against infections. Unlike it’s done with cancer types that affect other blood cells, it’s […]

November 14, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 14 Nov 2017

It’s World Diabetes Day! But What is Biotech Doing to Fight the Disease?

Diabetes is now a major epidemic, with 425 million people living with the condition. Luckily, biotech is working on ways to stop it in its tracks. Not only is it Antibiotic Awareness Week, but today is World Diabetes Day. This year’s theme draws attention to diabetes in women and the right to live a healthy life. […]

November 14, 2017 - 4 minutesmins - By Alex Dale

News and Trends 14 Nov 2017

Dutch RNA Firm Announces a Public Offering when its Stock is at an All-Time Low

ProQR is aiming to raise funds for clinical trials on the Nasdaq despite the fact that its stock has been down for a while now. ProQR is a biotech based in Leiden that develops RNA therapies for genetic disorders, with its lead program focused on cystic fibrosis. In order to fund clinical trials, research and […]

November 14, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

tusk therapeutics cancer CD38 immunotherapy 1

News and Trends 14 Nov 2017

British Biotech Gets a £2.5M Grant to Boost Cancer Immunotherapy

Tusk Therapeutics is working on immunotherapies to ignite the immune system against cancer. The £2.5M grant will help it to accelerate their development. Tusk Therapeutics focuses on immuno-oncology to ‘harness the power’ of the immune system. One of its candidates is an antibody that targets the CD38 immune checkpoint, which is a marker of cell activation that […]

November 14, 2017 - 2 minutesmins - By Alex Dale

In Depth 14 Nov 2017

The World’s Deadliest Diseases: How is Biotech Fighting Them?

With the recent outbreaks of plague in Madagascar and Ebola in West Africa, two terrifying diseases are back in the news. But these are not the only infections that are inevitably fatal if untreated, or, even worse, for which no therapy is available yet. Though mostly rare, deadly diseases are closer than you think. Plague […]

November 14, 2017 - 7 minutesmins - By Ute Boronowsky

Hubert Birner TVM Capital Bio Europe 2017

Interview 13 Nov 2017

Where is the Money Going in Biotech? A Peek into European VC Strategy

Hubert Birner, Managing Partner at TVM Capital Life Science, discusses his strategy to adapt to the European funding constraints and the areas with most potential for biotech investment. TVM Capital Life Science is a venture capital firm focusing on biotech, pharma and medtech. With over €900M under management and offices in both Munich and Montreal, TVM […]

November 13, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

New British Biotech Receives £3M to Develop Small Molecules that Fight Cancer

US Biotech Unicorn Steps up Competition for BioNTech’s mRNA Personalized Cancer Vaccine

Swiss Biotech Rakes in Biggest Fundraising of 2017 to Regenerate Heart Valves

Update: Belgian Biotech Starts Human Trials for a Potential Type 1 Diabetes Cure

Spanish Scientists’ Discovery Could be the End of Antibiotic-Resistant Superbugs

Therapeutic Nanoparticle Companies Are Rare: Meet the CEO of One of Them

This British Biotech Could Treat T-Cell Lymphoma without Leaving the Body Unprotected

It’s World Diabetes Day! But What is Biotech Doing to Fight the Disease?

Dutch RNA Firm Announces a Public Offering when its Stock is at an All-Time Low

British Biotech Gets a £2.5M Grant to Boost Cancer Immunotherapy

The World’s Deadliest Diseases: How is Biotech Fighting Them?

Where is the Money Going in Biotech? A Peek into European VC Strategy

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!